Syapse, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, has entered into a collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to leverage Syapse’s leading real-world evidence solutions designed to improve outcomes for cancer patients.